VeriMomsalicyloyl phytosphingosine은 임신 중 안전한가요?
No harmonised CLP classification, no SCCS or CIR reproductive safety assessment located, and no animal or human reproductive/teratology data were identified for salicyloyl phytosphingosine; published literature describes topical skin effects (procollagen, barrier repair) but not reproductive toxicity. The ingredient is a cosmetic sphingolipid derivative used at low % in topical products, so systemic exposure from normal cosmetic use is expected to be low but measurable. Sources: PubMed (dermatology/skin studies), PubChem/Chemical databases, EWG entry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
Pregnancy-safe products containing salicyloyl phytosphingosine
Related ingredients
Frequently asked questions
- salicyloyl phytosphingosine은 임신 중 안전한가요?
- No harmonised CLP classification, no SCCS or CIR reproductive safety assessment located, and no animal or human reproductive/teratology data were identified for salicyloyl phytosphingosine; published literature describes topical skin effects (procollagen, barrier repair) but not reproductive toxicity. The ingredient is a cosmetic sphingolipid derivative used at low % in topical products, so systemic exposure from normal cosmetic use is expected to be low but measurable. Sources: PubMed (dermatology/skin studies), PubChem/Chemical databases, EWG entry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- salicyloyl phytosphingosine은 모유 수유 중 안전한가요?
- No data on transfer into breast milk or breastfeeding-associated studies were found; with no reproductive or developmental toxicity signals and low expected systemic absorption from topical cosmetics, hazard is not indicated. Exposure is considered low but measurable as for pregnancy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- salicyloyl phytosphingosine은 아기 피부에 안전한가요?
- No infant‑specific toxicity data were identified. Following the user's scoring rules, because the ingredient has measurable (though low) dermal exposure in adults (see above) baby exposure is increased by +1 due to immature barrier and higher surface‑area‑to‑weight; there are still no data suggesting developmental/dermal hazard for infants. The literature describes topical skin benefits (barrier repair, anti‑inflammatory) rather than harm. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- VeriMom은 salicyloyl phytosphingosine을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 salicyloyl phytosphingosine을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 salicyloyl phytosphingosine 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.